Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
-
Published:2022-03
Issue:
Volume:163
Page:1-15
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Papamichael Demetris,
Lopes Guilherme S.,
Olswold Curt L.,
Douillard Jean-Yves,
Adams Richard A.,
Maughan Timothy S.,
Van Cutsem Eric,
Venook Alan P.ORCID,
Lenz Heinz-JosefORCID,
Heinemann Volker,
Kaplan RichardORCID,
Bokemeyer Carsten,
Chibaudel Benoist,
Grothey Axel,
Yoshino Takayuki,
Zalcberg JohnORCID,
De Gramont Aimery,
Shi QianORCID
Subject
Cancer Research,Oncology
Reference35 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018);Bray;Ca-Cancer J Clin.,2020
2. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors;Rawla;Gastroenterol Rev,2019
3. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer;Tappenden;Health Technol Asses,2007
4. Colorectal cancer treatment in elderly patients: an update on recent clinical studies;Merlin;Clin Colorectal Cancer,2008
5. Colorectal cancer statistics, 2020;Siegel;Ca-Cancer J Clin.,2020
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献